- First Release to Integrate Comprehensive Drug Pipeline Data andReal-Time Intelligence From Multiple Content Sources in a Single Search
Advertisement
Elsevier, a world-leading healthcare and scientific publisher, announcedtoday that it has reached an agreement with Tarrytown, New York basedInfoDesk to co-develop a federated drug pipeline intelligence solution forpharmaceutical and life science companies. The combination of Elsevier'sbusiness intelligence expertise and InfoDesk's technological know-how pavesthe way for the development of a powerful search and delivery tool that willincrease productivity and improve the quality of results, securely inside oroutside of a customer's firewall.
Advertisement
"We chose InfoDesk as our partner because they are content neutral andexcellent at supporting many diverse publishers, an essential capabilitygiven our goal of developing a tool that can search multiple content sources.They know how to take large feeds of data to help their clients deliverinformation to their users," explains Gerry Stoia, President of ElsevierBusiness Intelligence. "We're the content experts and they're the technologyexperts so it makes for a good marriage. We're in this together and we'revery excited about working with the InfoDesk team."
In a competitive market where 'go, no go' decisions have enormousfinancial implications, accurate, reliable data is mission critical. Buildingon the sophisticated synonym index developed as part of the UniversalIntegrator project initiated by Elsevier in 2007, InfoDesk will apply theirknowledge and experience to develop the new search tool. They anticipate thefirst release will be available in the second half of 2010.
"We've noticed our pharmaceutical customers are frustrated with the waydrug pipeline data is presented," observes Sterling Stites, President and CEOof InfoDesk. "There are many robust databases on the market, but with thepossible exception of a few information specialists, nobody actually likesthe process of using databases. Consequently, database usage stats are oftendisappointing. The real demand is for useful information that answers theuser's question. What InfoDesk brings to the table is our unique ability to'output' and actually 'push' content to users in a way that provides realanswers. That's what drives database usage."
There are three major benefits of a tool that can deliver accurate drugpipeline results from multiple content sources in real-time from a single,federated search.
Increased productivity
A fast, federated search of multiple content sources - either proprietaryor open access - will give users a single results set, increasingproductivity. With the new integrated solution, searches that used to takedays will take minutes.
Accurate results
Rich content drawn from a variety of sources will be filtered usingInfoDesk's advanced custom taxonomy, which can be modified to meet end-userrequirements. Elsevier's team of expert editors (MD and PhDs) will tag thedata at ingestion (when it is first compiled) and continuously monitor as thesources are updated. In addition, customer-defined taxonomy for specific usergroups and individuals will further increase the relevance of results. What'smore, InfoDesk's intelligent algorithms will rationalize data by contrastingand comparing results from multiple databases to ensure the reliability ofthe results.
Increased security
Unlike other web-based products on the market today that are hostedexternally, Elsevier and InfoDesk's new product can be hosted or installedinside a customer's firewall for greater security.
Additional modules are scheduled for release in 2011 and beyond whichwill give customers the opportunity to expand their federated search andintegrate their proprietary internal data.
To learn more visit either Elsevier Business Intelligence (Booth # 1232)or InfoDesk (Booth # 1422) at the Special Libraries Association (SLA) meetingin New Orleans, Louisiana from 13 to 16 June. To download a complimentarycopy of a white paper that examines the benefits of a federated search visithttp://tinyurl.com/28jszgd.
About InfoDesk
InfoDesk (http://www.infodesk.com/) is a technology company thatspecializes in providing secure, real-time, federated, personalized news andinformation services to companies, government agencies and otherorganizations.
Only InfoDesk's state-of-the-art content distribution platform combinessoftware products and applications for the acquisition, normalization andprocessing of information with a comprehensive range of intuitive tools forpersonalizing, receiving, viewing, searching, delivering and sharinginformation in real-time.
For more than a decade, InfoDesk has been the preferred informationresource management solution at some of the world's top corporate andgovernment enterprises. InfoDesk is headquartered in Tarrytown, New York withoffices in London and Washington DC.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. The company works in partnershipwith the global science and health communities to publish more than 2,000journals, including The Lancet (http://www.thelancet.com) and Cell(http://www.cell.com), and close to 20,000 book titles, including majorreference works from Mosby and Saunders. Elsevier's online solutions includeScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com),Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) andNursing Consult (http://www.nursingconsult.com), which enhance theproductivity of science and health professionals, and the SciVal suite(http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com),which help research and health care institutions deliver better outcomes morecost-effectively.
A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is partof Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leadingpublisher and information provider, which is jointly owned by Reed ElsevierPLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact: Sean Smith Director of Marketing, InfoDesk +1-202-365-6832 [email protected]
SOURCE InfoDesk and Elsevier
